This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ASML Announces 2012 Third-Quarter Results In Line With Guidance

ASML – Reconciliation U.S. GAAP – IFRS 1,2

Net income   Three months ended,     Nine months ended,
Sep 30,   Sep 25, Sep 30,   Sep 25,
2012 2011 2012 2011
(in millions EUR)                    
Net income based on U.S. GAAP 274.7 355.2 848.6 1,182.3
Development expenditures (see Note 1) 49.0 (8.6) 123.7 (28.0)
Share-based payments (see Note 2) 0.2 (0.4) 0.4 (0.6)
Reversal of write-downs (see Note 3) (0.4) (1.8) 6.8 1.2
Income taxes (see Note 4)   (0.9)   5.7       2.0   22.1
Net income based on IFRS 322.6 350.1 981.5 1,177.0
 
 
Shareholders’ equity Sep 30, Jul 1, Apr 1, Dec 31, Sep 25,
2012 2012 2012 2011 2011
(in millions EUR)                    
Shareholders’ equity based on U.S. GAAP 6,905.7 3,595.5 3,612.0 3,444.2 3,284.2
Development expenditures (see Note 1) 356.6 308.7 267.3 233.0 205.8
Share-based payments (see Note 2) 4.1 4.0 3.7 2.7 1.1
Reversal of write-downs (see Note 3) 14.0 14.4 6.5 7.2 3.8
Income taxes (see Note 4)   35.0   36.4   31.4   32.7   28.5
Equity based on IFRS 7,315.4 3,959.0 3,920.9 3,719.8 3,523.4
 

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Development expenditures

Under IFRS, ASML applies IAS 38, “Intangible Assets”. In accordance with IAS 38, ASML capitalizes certain development expenditures that are amortized over the expected useful life of the related product generally ranging between one and three years. Amortization starts when the developed product is ready for volume production.

8 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs